Article Text

PDF

Nuclear factor-kappa B (NF-kappaB) inducing kinase is preferentially expressed in rheumatoid arthritis synovial tissue containing ectopic lymphoid neogenesis
  1. A-R Noort1,
  2. K P M van Zoest1,
  3. M Modesti2,
  4. S W Tas1,
  5. P P Tak1
  1. 1Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands
  2. 2Department of Rheumatology, University of Rome, Rome, Italy

Statistics from Altmetric.com

Background and Objectives

In approximately 30% of patients with rheumatoid arthritis (RA), synovial inflammation is characterised by ectopic lymphoid neogenesis (ELN) resulting in ‘germinal centre-like’ structures that contain dendritic cells (DC) and aggregates of B and T cells. This process does not define a specific disease subset and also occurs in other types of chronic inflammation. Nuclear factor-kappaB (NF-kappaB) transcription factors are not only essential for the expression of proinflammatory cytokines, but also induce regulatory circuits. These regulatory properties are thought to be governed at least in part by the non-canonical NF-kappaB pathway of which NF-kappaB-inducing kinase (NIK) is a key mediator. Non-canonical NF-kappaB signalling can be triggered by stimuli like CD40L and lymphotoxin α1β2 that are abundantly present in ELN. In addition, non-canonical NF-kappaB signalling is involved in indoleamine-2,3-dioxygenase (IDO) expression in DC that can suppress T cell responses and promote tolerance. Recently it was demonstrated that these cells may play an important role in the balance between regulatory T cells (Tregs) and Th17 cells. We investigated the presence of regulatory mechanisms in RA synovial tissue (ST) in relationship to ELN. We therefore studied the expression and distribution of NIK, IDO, Foxp3 (as a marker of Tregs) and interleukin 17 (IL17) expressing cells in ST with and without ELN.

Methods

Using immunohistochemistry, we analysed the expression of NIK, IDO, Foxp3 and IL17 in ST of 40 RA patients. ST was obtained via mini-arthroscopy of inflamed knee or ankle joints of RA patients with active disease. Expression was scored on a semiquantitative 5-point scale (0–4) by two independent observers. Foxp3 expression was quantified by scoring the number of positive cells per HPF.

Results

ELN was present in 15 out of 40 RA ST. NIK expression was significantly higher in ST with ELN and more abundantly present within lymphocyte aggregates (1.53 + 0.32 vs 0.62 + 0.19; p<0.05). We also observed more Foxp3 positive cells in ST containing ELN (6.02 + 1.37 vs 4.36 + 1.31). IDO and IL17-expressing cells were found in ST with and without ELN, but no significant difference between the two types of synovial inflammation was found.

Conclusions

NIK is preferentially expressed in RA ST containing ELN in association with a trend towards more Tregs. This may point towards a regulatory role for the non-canonical NF-kappaB pathway in RA synovial inflammation, which could be exploited for the development of future new therapies.

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.